These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
513 related articles for article (PubMed ID: 29378706)
1. Zhao M; Lepak AJ; VanScoy B; Bader JC; Marchillo K; Vanhecker J; Ambrose PG; Andes DR Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378706 [TBL] [Abstract][Full Text] [Related]
2. Isavuconazole pharmacodynamic target determination for Candida species in an in vivo murine disseminated candidiasis model. Lepak AJ; Marchillo K; VanHecker J; Diekema D; Andes DR Antimicrob Agents Chemother; 2013 Nov; 57(11):5642-8. PubMed ID: 24002092 [TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model. Lepak AJ; Marchillo K; Andes DR Antimicrob Agents Chemother; 2015 Feb; 59(2):1265-72. PubMed ID: 25512406 [TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing Design. Lepak AJ; Zhao M; VanScoy B; Ambrose PG; Andes DR Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203480 [TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model. Andes D; Diekema DJ; Pfaller MA; Prince RA; Marchillo K; Ashbeck J; Hou J Antimicrob Agents Chemother; 2008 Feb; 52(2):539-50. PubMed ID: 18070979 [TBL] [Abstract][Full Text] [Related]
9. In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model. Andes DR; Diekema DJ; Pfaller MA; Marchillo K; Bohrmueller J Antimicrob Agents Chemother; 2008 Oct; 52(10):3497-503. PubMed ID: 18625768 [TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic Evaluation of Rezafungin (CD101) against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model. Lepak AJ; Zhao M; Andes DR Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181375 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis. Wiederhold NP; Najvar LK; Shaw KJ; Jaramillo R; Patterson H; Olivo M; Catano G; Patterson TF Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427304 [TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model. Andes D; Marchillo K; Stamstad T; Conklin R Antimicrob Agents Chemother; 2003 Oct; 47(10):3165-9. PubMed ID: 14506026 [TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis. Andes D; Marchillo K; Conklin R; Krishna G; Ezzet F; Cacciapuoti A; Loebenberg D Antimicrob Agents Chemother; 2004 Jan; 48(1):137-42. PubMed ID: 14693531 [TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model. Andes D; Stamsted T; Conklin R Antimicrob Agents Chemother; 2001 Mar; 45(3):922-6. PubMed ID: 11181381 [TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacodynamics and dose optimization of liposomal amphotericin B against Beredaki M-I; Arendrup MC; Pournaras S; Meletiadis J Antimicrob Agents Chemother; 2024 Aug; 68(8):e0022524. PubMed ID: 38958455 [TBL] [Abstract][Full Text] [Related]
16. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model. Fakhim H; Vaezi A; Dannaoui E; Chowdhary A; Nasiry D; Faeli L; Meis JF; Badali H Mycoses; 2018 Jun; 61(6):377-382. PubMed ID: 29460345 [TBL] [Abstract][Full Text] [Related]
17. Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata. Bader JC; Lakota EA; Flanagan S; Ong V; Sandison T; Rubino CM; Bhavnani SM; Ambrose PG Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555634 [TBL] [Abstract][Full Text] [Related]
18. In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model. Andes D; van Ogtrop M Antimicrob Agents Chemother; 2000 Apr; 44(4):938-42. PubMed ID: 10722494 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Kapoor M; Moloney M; Soltow QA; Pillar CM; Shaw KJ Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611349 [TBL] [Abstract][Full Text] [Related]
20. In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species. Andes D; Diekema DJ; Pfaller MA; Bohrmuller J; Marchillo K; Lepak A Antimicrob Agents Chemother; 2010 Jun; 54(6):2497-506. PubMed ID: 20385855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]